Trial
NCT05998863
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Osteoporosis
Intervention
EffCaMgCit
Why stopped
No enrollment due to COVID
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-30